IXICO PLC (IXI) — Investor Presentation

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the IXICO PLC Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged. They can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Simply type in your question at any time and press send. The company may not be in a position to answer every question received during the meeting itself. However, the company can review your questions submitted today, and we'll publish responses where it's appropriate to do so. Before we begin, we'd like to submit the following poll, and I'm sure the company may be most grateful for your participation. And I'd now like to hand over to CEO, Giulio Ciorone. Good afternoon. Thank you very much, Mark. Welcome, everybody. Thank you for attending today's call, where we're presenting IXICO's interim results for the first half of two thousand twenty four. I'm Giulio Ciorone, IXICO's CEO, and I'm joined today by Grant Nash, our CFO, and Robin Boltz, our chief scientific officer. You're gonna hear today how IXICO is in the business of unlocking the power of medical images with artificial intelligence in neurological disease trials. And whilst we've experienced a shortfall in anticipated bookings for the first half of the new year, why we're confident that we can make up ground in the second half of this year. This is evidenced by the fact that subsequent to the first half year ending March 30, we've signed new contracts and received notification of awards of competitive tenders that we anticipate contracting during the second half of this fiscal year. Grant will walk you through our financial results for the period outlining the cost control actions we took at the beginning of the ...